| Product Code: ETC11477551 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Cancer Cachexia Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Cancer Cachexia Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Cancer Cachexia Market - Industry Life Cycle |
3.4 Israel Cancer Cachexia Market - Porter's Five Forces |
3.5 Israel Cancer Cachexia Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Israel Cancer Cachexia Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Cancer Cachexia Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Israel Cancer Cachexia Market Revenues & Volume Share, By Mechanism, 2021 & 2031F |
4 Israel Cancer Cachexia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer cases in Israel |
4.2.2 Growing awareness about cancer cachexia among healthcare professionals and patients |
4.2.3 Rising healthcare expenditure and investments in oncology research and treatment |
4.3 Market Restraints |
4.3.1 High cost of cancer cachexia treatments |
4.3.2 Limited access to specialized care for cancer cachexia patients in certain regions of Israel |
4.3.3 Stringent regulations and reimbursement policies affecting market growth |
5 Israel Cancer Cachexia Market Trends |
6 Israel Cancer Cachexia Market, By Types |
6.1 Israel Cancer Cachexia Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Cancer Cachexia Market Revenues & Volume, By Treatment Type, 2021 - 2031F |
6.1.3 Israel Cancer Cachexia Market Revenues & Volume, By Pharmacological Therapy, 2021 - 2031F |
6.1.4 Israel Cancer Cachexia Market Revenues & Volume, By Nutritional Intervention, 2021 - 2031F |
6.2 Israel Cancer Cachexia Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Cancer Cachexia Market Revenues & Volume, By Weight Management, 2021 - 2031F |
6.2.3 Israel Cancer Cachexia Market Revenues & Volume, By Palliative Care, 2021 - 2031F |
6.3 Israel Cancer Cachexia Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Israel Cancer Cachexia Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.3 Israel Cancer Cachexia Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4 Israel Cancer Cachexia Market, By Mechanism |
6.4.1 Overview and Analysis |
6.4.2 Israel Cancer Cachexia Market Revenues & Volume, By Ghrelin Agonists, 2021 - 2031F |
6.4.3 Israel Cancer Cachexia Market Revenues & Volume, By Anti-Catabolic Agents, 2021 - 2031F |
7 Israel Cancer Cachexia Market Import-Export Trade Statistics |
7.1 Israel Cancer Cachexia Market Export to Major Countries |
7.2 Israel Cancer Cachexia Market Imports from Major Countries |
8 Israel Cancer Cachexia Market Key Performance Indicators |
8.1 Number of cancer cases diagnosed annually in Israel |
8.2 Percentage of oncologists trained in recognizing and managing cancer cachexia |
8.3 Research and development investments in cancer cachexia treatment options |
9 Israel Cancer Cachexia Market - Opportunity Assessment |
9.1 Israel Cancer Cachexia Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Israel Cancer Cachexia Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Cancer Cachexia Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Israel Cancer Cachexia Market Opportunity Assessment, By Mechanism, 2021 & 2031F |
10 Israel Cancer Cachexia Market - Competitive Landscape |
10.1 Israel Cancer Cachexia Market Revenue Share, By Companies, 2024 |
10.2 Israel Cancer Cachexia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here